HWPC(SH:688799) Sou Hu Cai Jing·2025-08-07 13:31Group 1 - Warner Pharmaceutical has experienced a decline for five consecutive trading days, with a cumulative drop of -10.00% [1] - Founded in 2001, Hunan Warner Pharmaceutical Co., Ltd. was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board in 2021 (stock code: 688799) and operates as an innovative drug manufacturing company covering traditional Chinese medicine, chemical drugs, and biopharmaceuticals [1] - Anxin Fund's Anxin Medical Health Stock A is among the top ten shareholders of Warner Pharmaceutical and has reduced its holdings in the second quarter of this year, achieving a year-to-date return of 69.42%, ranking 18th among 915 similar funds [1] Group 2 - The fund manager of Anxin Medical Health Stock A is Chi Chenshen, who holds a master's degree in economics and has previously worked as a researcher at various financial institutions [2][3] - Chi Chenshen has been managing the Anxin Medical Health Stock A fund since January 12, 2021, with a current fund size of 4.42 billion and a return of 65.80% during his tenure [3] - Anxin Fund Management Co., Ltd. was established in December 2011, with major shareholders including WISCO Capital Holdings Co., Ltd. (39.84%) and Guotou Securities Co., Ltd. (33.95%) [3]